This study confirms that MAPKK4 mediates energy metabolism dysfunction in endothelial cells and the activation of apoptosis-regulatory genes in the mitochondrial pathway after ischemia-reperfusion (IR) by regulating p38 activity. The gene discussed is MAP2K4; the disease is ischemia.